Sera Prognostics EBITDA Margin 2021-2025 | SERA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Sera Prognostics (SERA) over the last 10 years. The current EBITDA margin for Sera Prognostics as of June 30, 2025 is .
| Sera Prognostics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.00B | $-0.04B | 0.00% |
| 2025-03-31 | $0.00B | $-0.04B | 0.00% |
| 2024-09-30 | $0.00B | $-0.04B | 0.00% |
| 2024-06-30 | $0.00B | $-0.04B | 0.00% |
| 2023-12-31 | $0.00B | $-0.04B | 0.00% |
| 2023-09-30 | $0.00B | $-0.04B | 0.00% |
| 2023-06-30 | $0.00B | $-0.04B | 0.00% |
| 2023-03-31 | $0.00B | $-0.04B | 0.00% |
| 2022-12-31 | $0.00B | $-0.05B | 0.00% |
| 2022-09-30 | $0.00B | $-0.05B | 0.00% |
| 2022-06-30 | $0.00B | $-0.05B | 0.00% |
| 2022-03-31 | $0.00B | $-0.04B | 0.00% |
| 2021-12-31 | $0.00B | $-0.03B | 0.00% |
| 2021-06-30 | $0.00B | $-0.02B | 0.00% |
| 2021-03-31 | $0.00B | $-0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.085B | $0.000B |
| Sera Prognostics Inc. is a women's health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.946B | 28.18 |
| CVS Health (CVS) | United States | $90.013B | 11.19 |
| Elevance Health (ELV) | United States | $70.256B | 9.45 |
| Cencora (COR) | United States | $57.138B | 19.03 |
| DiDi Global (DIDIY) | China | $27.156B | 28.85 |
| Labcorp Holdings (LH) | United States | $22.916B | 18.22 |
| Natera (NTRA) | United States | $21.976B | 0.00 |
| BioMerieux (BMXMF) | France | $17.991B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.475B | 0.00 |
| ICON (ICLR) | Ireland | $14.507B | 13.96 |
| Medpace Holdings (MEDP) | United States | $12.983B | 34.36 |
| CochLear (CHEOY) | Australia | $12.561B | 0.00 |
| Solventum (SOLV) | United States | $12.531B | 12.93 |
| Viatris (VTRS) | United States | $12.452B | 4.43 |
| Revvity (RVTY) | United States | $10.611B | 18.69 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.386B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.321B | 0.00 |
| Avantor (AVTR) | United States | $8.849B | 12.98 |
| Charles River Laboratories (CRL) | United States | $7.799B | 14.80 |
| HealthEquity (HQY) | United States | $7.777B | 34.06 |
| Bausch + Lomb (BLCO) | Canada | $5.172B | 34.79 |
| Sotera Health (SHC) | United States | $4.590B | 25.65 |
| BrightSpring Health Services (BTSG) | United States | $4.106B | 31.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.466B | 79.38 |
| Surgery Partners (SGRY) | United States | $2.974B | 37.42 |
| Alignment Healthcare (ALHC) | United States | $2.951B | 0.00 |
| Concentras Parent (CON) | United States | $2.944B | 18.67 |
| Organon (OGN) | United States | $2.407B | 2.62 |
| Premier (PINC) | United States | $2.158B | 20.01 |
| Progyny (PGNY) | United States | $1.955B | 41.35 |
| Ardent Health (ARDT) | United States | $1.849B | 7.14 |
| PACS (PACS) | United States | $1.804B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.623B | 27.47 |
| Pediatrix Medical (MD) | United States | $1.436B | 9.59 |
| Teladoc Health (TDOC) | United States | $1.297B | 0.00 |
| Omada Health (OMDA) | $1.171B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.092B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.798B | 4.67 |
| AMN Healthcare Services Inc (AMN) | United States | $0.769B | 9.51 |
| CareDx (CDNA) | United States | $0.616B | 11.34 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| Agilon Health (AGL) | United States | $0.518B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 7.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.30 |
| Enhabit (EHAB) | United States | $0.409B | 26.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.392B | 0.00 |
| So-Young (SY) | China | $0.376B | 0.00 |
| Oncology Institute (TOI) | United States | $0.341B | 0.00 |
| LifeMD (LFMD) | United States | $0.290B | 0.00 |
| Beauty Health (SKIN) | United States | $0.274B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| ModivCare (MODV) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |